ES2339307T3 - LITTLE VISCOSE COSMETIC OR DERMATOLOGICAL PREPARATIONS OF THE WATER-IN-OIL TYPE. - Google Patents
LITTLE VISCOSE COSMETIC OR DERMATOLOGICAL PREPARATIONS OF THE WATER-IN-OIL TYPE. Download PDFInfo
- Publication number
- ES2339307T3 ES2339307T3 ES98118102T ES98118102T ES2339307T3 ES 2339307 T3 ES2339307 T3 ES 2339307T3 ES 98118102 T ES98118102 T ES 98118102T ES 98118102 T ES98118102 T ES 98118102T ES 2339307 T3 ES2339307 T3 ES 2339307T3
- Authority
- ES
- Spain
- Prior art keywords
- cosmetic
- acid
- preparations
- acids
- dermatological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title claims abstract description 48
- 229920000297 Rayon Polymers 0.000 title 1
- 239000003921 oil Substances 0.000 claims abstract description 30
- 239000003792 electrolyte Substances 0.000 claims abstract description 25
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 16
- 239000008346 aqueous phase Substances 0.000 claims abstract description 14
- 239000003925 fat Substances 0.000 claims abstract description 8
- 239000001993 wax Substances 0.000 claims abstract description 7
- 239000000654 additive Substances 0.000 claims abstract description 6
- 239000002253 acid Substances 0.000 claims description 56
- 239000000126 substance Substances 0.000 claims description 34
- 150000007513 acids Chemical class 0.000 claims description 26
- 150000003839 salts Chemical class 0.000 claims description 20
- 230000001804 emulsifying effect Effects 0.000 claims description 10
- 239000012074 organic phase Substances 0.000 claims description 10
- 150000001413 amino acids Chemical class 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 5
- 239000004904 UV filter Substances 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- 239000003981 vehicle Substances 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 11
- 239000007788 liquid Substances 0.000 abstract description 7
- 229920006395 saturated elastomer Polymers 0.000 abstract description 7
- 125000000217 alkyl group Chemical group 0.000 abstract description 5
- 239000004094 surface-active agent Substances 0.000 abstract description 4
- 239000012071 phase Substances 0.000 abstract description 3
- 239000013543 active substance Substances 0.000 abstract description 2
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000004417 unsaturated alkyl group Chemical group 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000005690 diesters Chemical class 0.000 abstract 1
- 125000005702 oxyalkylene group Chemical group 0.000 abstract 1
- 229920000728 polyester Polymers 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 27
- 210000003491 skin Anatomy 0.000 description 21
- 235000002639 sodium chloride Nutrition 0.000 description 20
- -1 2-oxo-3-bornylidenmethyl Chemical group 0.000 description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 14
- 150000002148 esters Chemical class 0.000 description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 12
- 239000003963 antioxidant agent Substances 0.000 description 12
- 235000006708 antioxidants Nutrition 0.000 description 12
- 239000000839 emulsion Substances 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 150000001298 alcohols Chemical class 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 235000013772 propylene glycol Nutrition 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 229920002545 silicone oil Polymers 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 150000001450 anions Chemical class 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 229930195733 hydrocarbon Natural products 0.000 description 5
- 150000002430 hydrocarbons Chemical class 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000007762 w/o emulsion Substances 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical class CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- 206010001488 Aggression Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 229940124091 Keratolytic Drugs 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- 239000005662 Paraffin oil Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000016571 aggressive behavior Effects 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 125000005210 alkyl ammonium group Chemical group 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 150000008366 benzophenones Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 229960002433 cysteine Drugs 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 239000001023 inorganic pigment Substances 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- 230000001530 keratinolytic effect Effects 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229940070721 polyacrylate Drugs 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 150000003458 sulfonic acid derivatives Chemical class 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- PDHSAQOQVUXZGQ-JKSUJKDBSA-N (2r,3s)-2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2h-chromene-5,7-diol Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2OC)=CC=C(O)C(O)=C1 PDHSAQOQVUXZGQ-JKSUJKDBSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- AALXZHPCKJILAZ-UHFFFAOYSA-N (4-propan-2-ylphenyl)methyl 2-hydroxybenzoate Chemical compound C1=CC(C(C)C)=CC=C1COC(=O)C1=CC=CC=C1O AALXZHPCKJILAZ-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical class CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- QYXHQRJWUMDWGJ-UHFFFAOYSA-N 2-[(4-methoxyphenyl)methylidene]propanedioic acid Chemical compound COC1=CC=C(C=C(C(O)=O)C(O)=O)C=C1 QYXHQRJWUMDWGJ-UHFFFAOYSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N 2-amino-4-methylselanyl-butanoic acid Chemical compound C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- KXTAOXNYQGASTA-UHFFFAOYSA-N 2-benzylidenepropanedioic acid Chemical compound OC(=O)C(C(O)=O)=CC1=CC=CC=C1 KXTAOXNYQGASTA-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- IQXWVZRMYFOEQO-UHFFFAOYSA-N 2-methyl-5-[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid Chemical compound C1=C(S(O)(=O)=O)C(C)=CC=C1C=C1C(=O)C2(C)CCC1C2(C)C IQXWVZRMYFOEQO-UHFFFAOYSA-N 0.000 description 1
- KVZLHPXEUGJPAH-UHFFFAOYSA-N 2-oxidanylpropanoic acid Chemical compound CC(O)C(O)=O.CC(O)C(O)=O KVZLHPXEUGJPAH-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-L 3-(2-carboxylatoethylsulfanyl)propanoate Chemical compound [O-]C(=O)CCSCCC([O-])=O ODJQKYXPKWQWNK-UHFFFAOYSA-L 0.000 description 1
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 1
- GWXXFGWOWOJEEX-UHFFFAOYSA-N 4,4,4-trihydroxy-1-phenylbutan-1-one Chemical compound OC(CCC(=O)C1=CC=CC=C1)(O)O GWXXFGWOWOJEEX-UHFFFAOYSA-N 0.000 description 1
- UNRLBSCNZNCQTK-UHFFFAOYSA-N 4-(dimethylamino)pentyl benzoate Chemical compound CN(C)C(C)CCCOC(=O)C1=CC=CC=C1 UNRLBSCNZNCQTK-UHFFFAOYSA-N 0.000 description 1
- KKJKXQYVUVWWJP-UHFFFAOYSA-N 4-[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid Chemical compound CC1(C)C2CCC1(C)C(=O)C2=CC1=CC=C(S(O)(=O)=O)C=C1 KKJKXQYVUVWWJP-UHFFFAOYSA-N 0.000 description 1
- 150000005418 4-aminobenzoic acid derivatives Chemical class 0.000 description 1
- SJIDAAGFCNIAJP-UHFFFAOYSA-N 6-methylheptyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCC(C)C SJIDAAGFCNIAJP-UHFFFAOYSA-N 0.000 description 1
- XUVVLJKRLAXOKZ-UHFFFAOYSA-N 7-methyloctyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCC(C)C XUVVLJKRLAXOKZ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 108010085443 Anserine Proteins 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- XHVAWZZCDCWGBK-WYRLRVFGSA-M Aurothioglucose Chemical compound OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O XHVAWZZCDCWGBK-WYRLRVFGSA-M 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-MGCNEYSASA-N D-galactonic acid Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-MGCNEYSASA-N 0.000 description 1
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
- 239000003508 Dilauryl thiodipropionate Substances 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 description 1
- 241000173371 Garcinia indica Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 101500021084 Locusta migratoria 5 kDa peptide Proteins 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000210053 Potentilla elegans Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- ARCJQKUWGAZPFX-KBPBESRZSA-N S-trans-stilbene oxide Chemical compound C1([C@H]2[C@@H](O2)C=2C=CC=CC=2)=CC=CC=C1 ARCJQKUWGAZPFX-KBPBESRZSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000003490 Thiodipropionic acid Substances 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2r)-2-[(3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 1
- JPWFLGRTTWURLS-UHFFFAOYSA-N [2-hydroxy-3-[2-hydroxy-3-(12-hydroxyoctadecanoyloxy)propoxy]propyl] 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCCCCCC(O)CCCCCC JPWFLGRTTWURLS-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 150000004645 aluminates Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229960001799 aurothioglucose Drugs 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 208000027687 belching Diseases 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- CSNNWDJQKGMZPO-UHFFFAOYSA-N benzoic acid;2-hydroxy-1,2-diphenylethanone Chemical compound OC(=O)C1=CC=CC=C1.C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 CSNNWDJQKGMZPO-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 1
- 229940085262 cetyl dimethicone Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- 235000019304 dilauryl thiodipropionate Nutrition 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- HEAHZSUCFKFERC-UHFFFAOYSA-N ecamsule Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC(C=C1)=CC=C1C=C1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C HEAHZSUCFKFERC-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004872 foam stabilizing agent Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- HTDJPCNNEPUOOQ-UHFFFAOYSA-N hexamethylcyclotrisiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O1 HTDJPCNNEPUOOQ-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910001412 inorganic anion Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical group [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229940048845 polyglyceryl-3 diisostearate Drugs 0.000 description 1
- 229940100518 polyglyceryl-4 isostearate Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- PZQSQRCNMZGWFT-QXMHVHEDSA-N propan-2-yl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C PZQSQRCNMZGWFT-QXMHVHEDSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical class [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- ARCJQKUWGAZPFX-UHFFFAOYSA-N stilbene oxide Chemical compound O1C(C=2C=CC=CC=2)C1C1=CC=CC=C1 ARCJQKUWGAZPFX-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000012747 synergistic agent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 235000019303 thiodipropionic acid Nutrition 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000003253 viricidal effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
Preparados cosméticos o dermatológicos poco viscosos del tipo agua-en-aceite.Cosmetic or dermatological preparations little viscous type water-in-oil.
La presente invención se refiere a preparados cosméticos y dermatológicos del tipo agua-en-aceite, a procesos para su elaboración y a su uso con fines cosméticos y medicinales.The present invention relates to preparations cosmetic and dermatological type water-in-oil, to processes for its elaboration and its use for cosmetic and medicinal purposes.
La piel humana, como órgano corporal de mayor extensión, ejerce diversas funciones de vital importancia. Con unos 2 m^{2} de superficie en los adultos le corresponde un papel predominante como órgano protector y sensorial. Su misión es hacer de barrera defensiva contra agresiones mecánicas, térmicas, actínicas, químicas y biológicas. Además tiene un papel significativo como órgano regulador y receptor del metabolismo humano.Human skin, as a major body organ extension, exerts various functions of vital importance. With some 2 m 2 of surface area in adults corresponds to a role predominant as a protective and sensory organ. Your mission is to do of defensive barrier against mechanical, thermal aggressions, Actinic, chemical and biological. It also has a role significant as a regulatory and metabolic receptor organ human.
Como cuidado cosmético de la piel hay que entender ante todo el refuerzo o restablecimiento de su función natural de barrera contra los agentes externos (p. ej. suciedad, productos químicos, microorganismos) y contra la pérdida de sustancias corporales (p. ej. agua, grasas naturales, electrolitos), así como la protección del poder natural de regeneración de su capa córnea cuando está dañada.As cosmetic skin care you have to understand first of all the reinforcement or restoration of its function natural barrier against external agents (eg dirt, chemicals, microorganisms) and against the loss of body substances (eg water, natural fats, electrolytes), as well as the protection of the natural power of regeneration of its layer Cornea when damaged.
Cuando se alteran las propiedades de barrera de la piel puede producirse una mayor resorción de sustancias tóxicas o alérgenas o el ataque de microorganismos y, por tanto, reacciones cutáneas tóxicas o alérgicas.When the barrier properties of the skin can produce a greater resorption of toxic substances or allergens or the attack of microorganisms and therefore reactions toxic or allergic skin.
La higiene cutánea también por objeto compensar la pérdida de grasa y agua causada por el lavado diario de la piel, lo cual es importante, precisamente, cuando no basta el poder de regeneración natural. Asimismo, los productos de higiene cutánea deben proteger la piel de los agentes externos, sobre todo del sol y del viento, y retrasar su envejecimiento.The skin hygiene also for the purpose of compensating the loss of fat and water caused by daily skin washing, which is important precisely when the power of natural regeneration Also, skin hygiene products they must protect the skin from external agents, especially from the sun and of the wind, and delay its aging.
Las composiciones medicinales de uso tópico suelen contener uno o varios medicamentos en concentración efectiva. En aras de la simplicidad, para distinguir claramente entre uso cosmético y uso medicinal, y los correspondientes productos, se remite a las disposiciones legales de la República Federal de Alemania (p. ej. reglamento de cosmética, ley de productos alimenticios y farmacéuticos).Topical medicinal compositions They usually contain one or several medications in effective concentration. For the sake of simplicity, to clearly distinguish between use cosmetic and medicinal use, and the corresponding products, are refers to the legal provisions of the Federal Republic of Germany (eg cosmetic regulation, product law food and pharmaceutical).
Como emulsiones hay que entender de manera general los sistemas heterogéneos formados por dos líquidos inmiscibles o poco miscibles entre sí, llamados habitualmente fases. En una emulsión, uno de los dos líquidos está dispersado en forma de gotas muy finas en el otro líquido.As emulsions you have to understand in a way general heterogeneous systems formed by two liquids immiscible or poorly miscible with each other, usually called phases. In an emulsion, one of the two liquids is dispersed in the form of very fine drops in the other liquid.
Cuando ambos líquidos son agua y aceite y hay gotitas de aceite finamente dispersas en agua, se trata de una emulsión aceite-en-agua (emulsión O/W, p. ej. leche). El carácter fundamental de una emulsión O/W viene marcado por el agua. En el caso de una emulsión agua-en-aceite (emulsión W/O, p. ej. mantequilla) se trata del principio contrario, y por tanto aquí el carácter fundamental viene marcado por el aceite.When both liquids are water and oil and there are oil droplets finely dispersed in water, this is a oil-in-water emulsion (emulsion O / W, p. ex. milk). The fundamental character of an O / W emulsion It is marked by water. In the case of an emulsion water-in-oil (W / O emulsion, e.g. butter) is the opposite principle, and therefore here the fundamental character is marked by oil.
En cuanto al mantenimiento de sustancias en la piel, por ejemplo los absorbentes de UV y los hidratantes, los productos cosméticos y dermatológicos en forma de formulaciones W/O tienen ventajas sobre las formulaciones O/W.Regarding the maintenance of substances in the skin, for example UV absorbers and moisturizers, Cosmetic and dermatological products in the form of W / O formulations They have advantages over O / W formulations.
Naturalmente el especialista conoce muchas alternativas para formular preparados W/O estables de uso cosmético o dermatológico, por ejemplo en forma de cremas y pomadas, aplicables a una temperatura comprendida entre la ambiental y la de la piel, o en forma de lociones y leches, que son más fluidas en este intervalo de temperatura. Sin embargo, en el estado técnico se conocen pocas formulaciones que sean suficientemente fluidas como para pulverizarlas, por ejemplo.Naturally the specialist knows many alternatives to formulate stable W / O preparations for cosmetic use or dermatological, for example in the form of creams and ointments, applicable at a temperature between environmental and the skin, or in the form of lotions and milks, which are more fluid in This temperature range. However, in the technical state it they know few formulations that are sufficiently fluid as to spray them, for example.
Además los preparados de baja viscosidad conocidos del estado técnico tienen a menudo el inconveniente de ser inestables y estar limitados a un estrecho margen de aplicación o a una selección restringida de sustancias. Por consiguiente no existen hoy en día en el mercado productos de baja viscosidad que contengan, por ejemplo, aceites muy polares -como los aceites vegetales usados con frecuencia en los productos comerciales- suficientemente estabilizados.In addition, low viscosity preparations known in the technical state often have the disadvantage of be unstable and be limited to a narrow range of application or to a restricted selection of substances. Therefore not today there are low viscosity products on the market that contain, for example, very polar oils - like oils vegetables frequently used in commercial products- sufficiently stabilized
Emulsiones W/O de baja viscosidad y estables al almacenamiento como requieren los productos corrientes del mercado solo se pueden formular de manera muy laboriosa. Por ello la oferta de tales formulaciones es sumamente baja. No obstante, hasta la fecha, dichas formulaciones no han podido ofrecer al usuario las prestaciones cosméticas conocidas.W / O emulsions of low viscosity and stable at storage as current market products require They can only be formulated very laboriously. Therefore the offer of such formulations is extremely low. However, until date, these formulations have not been able to offer the user the known cosmetic benefits.
Un serio inconveniente de las emulsiones del estado técnico es a menudo su falta de estabilidad frente a concentraciones altas de electrolitos, que se traduce en separación de fases. Pero frecuentemente es preferible emplear determinados electrolitos, como por ejemplo filtros UV hidrosolubles, para poder aprovechar sus especiales características físicas, químicas o fisiológicas. Aunque en muchos casos esto puede remediarse en cierta medida eligiendo el sistema emulsionante apropiado, luego también surgen otras desventajas.A serious inconvenience of the emulsions of the technical status is often its lack of stability against high concentrations of electrolytes, which results in separation of phases. But it is often preferable to use certain electrolytes, such as water-soluble UV filters, to be able to take advantage of its special physical, chemical or physiological Although in many cases this can be remedied in a certain way. measure by choosing the appropriate emulsifying system, then also Other disadvantages arise.
Dichas desventajas pueden deberse por ejemplo a que los emulsionantes, como al fin y al cabo cualquier sustancia química, pueden causar reacciones de alergia o de hipersensibilidad en el usuario, aunque naturalmente el uso de los emulsionantes habituales en cosmética es en general inocuo.Such disadvantages may be due for example to that emulsifiers, as after all substance chemical, can cause allergy or hypersensitivity reactions in the user, although of course the use of emulsifiers Usual in cosmetics is generally harmless.
\global\parskip0.950000\baselineskip\ global \ parskip0.950000 \ baselineskip
Las concentraciones de todos los ingredientes de un preparado cosmético o dermatológico suelen indicarse en unidades como % en peso, % molar, etc. Debido a su disociación más o menos fuerte en cationes y aniones -con frecuencia en varias etapas de disociación- en el caso de la presente invención parece más oportuno partir de la fuerza iónica de un determinado electrolito en su disolución.The concentrations of all the ingredients of a cosmetic or dermatological preparation is usually indicated in units as% by weight,% molar, etc. Due to its dissociation more or less strong in cations and anions - often in several stages of dissociation - in the case of the present invention it seems more appropriate from the ionic strength of a given electrolyte in its dissolution.
La fuerza iónica I de una disolución de electrolito se define comoThe ionic strength I of an electrolyte solution is defined as
donde c_{1} representa la concentración de cada especie iónica (en moles/l) y z_{1} su índice de carga. La unidad física de la fuerza iónica es la de una concentración (moles/l).where c 1 represents the concentration of each ionic species (in moles / l) and z 1 its charge index. The physical unit of the ionic force is that of a concentration (moles / l).
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Por ejemplo, una disolución de cloruro sódico al 1% (es decir 0,17-molar) tiene por consiguiente una fuerza iónica de I = 0,17 moles/l.For example, a 1% solution of sodium chloride (i.e. 0.17-molar) therefore has an ionic strength of I = 0.17 mol / l.
En la literatura (p. ej. Seife, Öle, Fette, Wachse [Jabones, aceites, grasas, ceras], volumen 110 (15), pág. 427 y sigtes.) se describen preparados cosméticos del tipo agua-en-aceite que contienen una fase orgánica, una fase acuosa cuya fuerza iónica es 1,7 y un sistema emulsionante.In the literature (eg Seife, Öle, Fette, Wachse [Soaps, oils, fats, waxes], volume 110 (15), p. 427 et seq.) Cosmetic preparations of the type are described water-in-oil containing a organic phase, an aqueous phase whose ionic strength is 1.7 and a emulsifying system
La patente US 5162378 revela preparados cosméticos del tipo agua-en-aceite, cuya fase acuosa lleva 8-20% de electrolitos y el sistema emulsionante un éster de poliglicerina y ácido graso.US 5162378 discloses preparations water-in-oil type cosmetics, whose aqueous phase carries 8-20% electrolytes and the emulsifying system an ester of polyglycerin and fatty acid.
La patente WO 9817232 revela un preparado cosmético del tipo agua-en-aceite, que comprende una mezcla de varios emulsionantes W/O y contiene sales orgánicas en la fase acuosa.WO 9817232 discloses a preparation water-in-oil type cosmetic, which comprises a mixture of several W / O emulsifiers and contains organic salts in the aqueous phase.
La patente EP 834306 describe preparados cosméticos del tipo agua-en-aceite, cuya fase acuosa contiene al menos 2% en peso de electrolitos y el sistema emulsionante comprende un éster de poliglicerina y ácido graso.EP 834306 describes preparations water-in-oil type cosmetics, whose aqueous phase contains at least 2% by weight of electrolytes and the emulsifying system comprises an ester of polyglycerin and acid fatty.
La patente DE 4126969 describe preparados cosméticos del tipo agua-en-aceite, cuya fase acuosa contiene al menos 2% en peso de electrolitos y el sistema emulsionante lleva copoliol cetil dimeticona, poligliceril-4-isoestearato y laurato de hexilo.DE 4126969 describes preparations water-in-oil type cosmetics, whose aqueous phase contains at least 2% by weight of electrolytes and the emulsifying system carries copolyol cetyl dimethicone, polyglyceryl-4-isostearate and hexyl laurate
La patente DE 4243119 describe preparados cosméticos del tipo agua-en-aceite, que contienen una combinación emulsionante de tres componentes en la que hay poligliceril-3-diiso-estearato.DE 4243119 describes preparations water-in-oil type cosmetics, containing an emulsifying combination of three components in the what's up polyglyceryl-3-diiso-stearate.
La patente DE 4420516 revela el empleo de poliglicerin-polihidroxiestearatos como emulsionantes W/O para preparados cosméticos.Patent DE 4420516 discloses the use of polyglycerin-polyhydroxystearates as W / O emulsifiers for cosmetic preparations.
Un objetivo de la presente invención era elaborar preparados del tipo agua-en-aceite que tuvieran muy baja viscosidad, pero sin las desventajas del estado técnico. Otro objetivo de la presente invención era revelar vías de solución para emulsiones W/O cosméticas o dermatológicas lo menos viscosas posible, que fueran estables frente a grandes concentraciones de electrolito - o elevadas fuerzas iónicas.An objective of the present invention was prepare type preparations water-in-oil that had very low viscosity, but without the disadvantages of the technical state. Other objective of the present invention was to reveal solution paths for least viscous cosmetic or dermatological W / O emulsions possible, that they were stable against large concentrations of electrolyte - or high ionic forces.
Estos objetivos se resuelven sorprendentemente con preparados cosméticos o dermatológicos del tipo agua-en-aceite, de baja viscosidad, que contienenThese goals are surprisingly resolved with cosmetic or dermatological preparations of the type water-in-oil, low viscosity, that contain
- (1)(one)
- una fase orgánica que lleva uno o varios aceites, grasas y/o ceras;a organic phase that carries one or more oils, fats and / or waxes;
- (2)(2)
- una fase acuosa que lleva disueltos uno o varios electrolitos, siendo la fuerza iónica de la fase acuosa de 0,075 moles/l como mínimo, y a aqueous phase that has dissolved one or more electrolytes, the ionic strength of the aqueous phase of at least 0.075 mol / l, Y
- (3)(3)
- un sistema emulsionante, formado por al menos dos emulsionantes escogidos del grupo constituido por poligliceril-3-diisoestearato, poligliceril-2-polihidroxi-estearato, PEG-30-dipolihidroxiestearato y, si se desea, sustancias auxiliares, aditivos y/o principios activos cosméticos o dermatológicos habituales. a emulsifying system, consisting of at least two emulsifiers chosen from the group consisting of polyglyceryl-3-diisoestearate, polyglyceryl-2-polyhydroxy stearate, PEG-30-dipolihydroxystearate and, yes desired, auxiliary substances, additives and / or active ingredients usual cosmetic or dermatological.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
La viscosidad de los preparados es menor de 2.000 mPa\cdots.The viscosity of the preparations is less than 2,000 mPa \ cdots.
Para el especialista era imprevisible que los preparados según la presente invenciónFor the specialist it was unpredictable that prepared according to the present invention
- --
- fueran más fáciles de formular,were easier to formulate,
- --
- tuvieran mayor estabilidad frente a una descomposición en las fases orgánica y acuosa, ythey had greater stability against a decomposition in the organic and aqueous phases, and
- --
- mejores propiedades sensoriales, como por ejemplo facilidad de aplicación sobre la piel o capacidad de penetración en la misma, que los preparados del estado técnico.better sensory properties, such as for example ease of application on the skin or ability to insight into it, that state preparations technical.
\global\parskip1.000000\baselineskip\ global \ parskip1.000000 \ baselineskip
Los preparados de la presente invención suponen por lo tanto un enriquecimiento del estado técnico como emulsiones W/O de baja viscosidad estables frente a electrolitos.The preparations of the present invention assume therefore an enrichment of the technical state as emulsions Low viscosity W / O stable against electrolytes.
Tanto la patente alemana 44 09 569 como la solicitud de patente alemana 44 20 516 ya describen emulsionantes W/O en forma de poliglicerinpoliricinoleatos o de poliolpolihidroxi-estearatos, que dan emulsiones igualmente estables de baja viscosidad con diversos aceites. No obstante, en los ejemplos ahí mencionados resulta que las formulaciones "poco viscosas" tienen una viscosidad mínima de 8.000 mPa\cdots. En general la viscosidad de dichos ejemplos es incluso claramente superior a un valor de 10.000 mPa\cdots.Both German patent 44 09 569 and the German patent application 44 20 516 already describe emulsifiers W / O in the form of polyglycerinpolyricinoleates or polyol polyhydroxy stearates, which give emulsions equally stable of low viscosity with various oils. Do not However, in the examples mentioned therein it turns out that "low viscosity" formulations have a minimum viscosity of 8,000 mPa \ cdots. In general the viscosity of such examples is even clearly exceeding a value of 10,000 mPa \ cdots.
Por lo que respecta a la incorporación de electrolitos, el estado técnico según los dos documentos DE 44 09 569 C1 y DE 44 20 516 A1 tampoco va en el camino de la presente invención. Según las descripciones y los ejemplos estos preparados también pueden contener sales. Sin embargo en el lugar citado solo se indica sulfato magnésico como electrolito para este uso.As regards the incorporation of electrolytes, the technical status according to the two documents DE 44 09 569 C1 and DE 44 20 516 A1 also does not go in the way of the present invention. According to the descriptions and examples these prepared They may also contain salts. However in the place cited only magnesium sulfate is indicated as electrolyte for this use.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Según la presente invención han resultado especialmente ventajosos los sistemas emulsionantes en que al menos uno de ambos emulsionantes es poligliceril-3-diisoestearato.According to the present invention they have resulted especially advantageous emulsifying systems in which at least one of both emulsifiers is polyglyceryl-3-diisoestearate.
Estos ésteres de ácido isoesteárico pueden adquirirse, por ejemplo, bajo la denominación de producto "Lameform TGI" de la firma Henkel KGaA.These isostearic acid esters can acquired, for example, under the product designation "Lameform TGI" by Henkel KGaA.
Según la presente invención han resultado especialmente ventajosos los sistemas emulsionantes en que al menos uno de ambos emulsionantes es "poligliceril-2-polihidroxiestearato", que está registrado con los números 156531-21-4 y 144470-58-6 en el "Chemical Abstracts" y que puede obtenerse con la marca comercial DEHYMULS® PGPH de Henkel KGaA.According to the present invention they have resulted especially advantageous emulsifying systems in which at least one of both emulsifiers is "polyglyceryl-2-polyhydroxystearate", which is registered with the numbers 156531-21-4 and 144470-58-6 in the "Chemical Abstracts "and that can be obtained with the trademark DEHYMULS® PGPH by Henkel KGaA.
Según la presente invención es muy especialmente ventajoso que uno de ambos emulsionantes sea PEG-30-dipolihidroxi-estearato, que vende la compañía ICI Surfactants con la marca comercial ARLACEL® P135.According to the present invention it is very especially advantageous that one of both emulsifiers is PEG-30-dipolihydroxy stearate, sold by the company ICI Surfactants with the trademark ARLACEL® P135.
La condición para el empleo de los emulsionantes arriba descritos, según los propósitos de la presente invención, es naturalmente que las sustancias utilizadas sean inocuas desde el punto de vista cosmético y dermatológico.The condition for the use of emulsifiers described above, according to the purposes of the present invention, is naturally, the substances used are safe from cosmetic and dermatological point of view.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Según la presente invención, el o los electrolitos se eligen ventajosamente de los siguientes grupos (1) a (3):According to the present invention, the one or more electrolytes are advantageously chosen from the following groups (1) to (3):
(1) Ciertas sustancias filtrantes de UV, casi siempre en forma de sales alcalinas, especialmente las que llevan en su estructura molecular uno o más grupos ácido sulfónico o sulfonato. Como ejemplos cabe citar en este caso: el ácido 2-fenilbenzimidazol-5-sulfónico y sus sales, por ejemplo de sodio, potasio o trietilamonio(1) Certain UV filter substances, almost always in the form of alkaline salts, especially those that carry its molecular structure one or more sulfonic acid groups or sulphonate As examples we can mention in this case: the acid 2-phenylbenzimidazol-5-sulfonic and its salts, for example sodium, potassium or triethylammonium
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
derivados de ácido sulfónico de benzofenonas, preferentemente el ácido 2-hidroxi-4-metoxibenzofenon-5-sulfónico y sus sales, por ejemplo de sodio, potasio o tri-etilamonio:sulfonic acid derivatives of benzophenones, preferably acid 2-hydroxy-4-methoxybenzophenon-5-sulfonic and its salts, for example sodium, potassium or tri-ethylammonium:
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\newpage\ newpage
derivados de ácido sulfónico del 3-benciliden-alcanfor, como p. ej. el ácido 4-(2-oxo-3-bornilidenmetil)-benceno sulfónico y sus sales, por ejemplo de sodio, potasio o trietilamonio:sulfonic acid derivatives of 3-benzylidene-camphor, as p. ex. the acid 4- (2-oxo-3-bornylidenmethyl) -benzene sulfonic acid and its salts, for example sodium, potassium or triethylammonium:
el ácido 2-metil-5-(2-oxo-3-bornilidenmetil)-benceno-sulfónico y sus sales, por ejemplo de sodio, potasio o trietilamonio:the acid 2-methyl-5- (2-oxo-3-bornylidenmethyl) -benzene sulfonic acid and its salts, for example sodium, potassium or triethylammonium:
el 1,4-di(2-oxo-10-sulfo-3-bornilidenmetil)-benceno y sus sales (los respectivos compuestos 10-sulfato, por ejemplo de sodio, potasio o trietilamonio), también llamado ácido 1,4-di(2-oxo-3-bornilidenmetil)-10-sulfónico:he 1,4-di (2-oxo-10-sulfo-3-bornylidenmethyl) -benzene and its salts (the respective 10-sulfate compounds, for example sodium, potassium or triethylammonium), also called acid 1,4-di (2-oxo-3-bornylidenmethyl) -10-sulfonic:
(2) Aminoácidos y sus sales o aniones.(2) Amino acids and their salts or anions.
Los aminoácidos forman parte del factor natural de hidratación (el llamado "Natural Moisturizing Factor"): El manto hidrolípido es la capa más externa que regula el contenido de humedad en la capa córnea. Dentro de la capa córnea, es decir, desde la epidermis viva hasta la superficie, hay una fuerte caída de humedad. Los componentes hidrosolubles constituyen la mezcla conocida como "Natural Moisturizing Factor" (NMF), que es hidrófila y débilmente higroscópica y posee importantes funciones.Amino acids are part of the natural factor. of hydration (the so-called "Natural Moisturizing Factor"): The Hydrolipid mantle is the outermost layer that regulates the content of moisture in the corneal layer. Inside the cornea layer, that is, from the epidermis alive to the surface, there is a sharp fall in humidity. The water-soluble components constitute the mixture known as "Natural Moisturizing Factor" (NMF), which is hydrophilic and weakly hygroscopic and has important functions.
Por lo tanto la adición de aminoácidos, especialmente de aminoácidos esenciales, debe considerarse ventajosa, pues mediante procesos de hidratación puede fijarse humedad en la piel.Therefore the addition of amino acids, especially essential amino acids, should be considered advantageous, because hydration processes can be set moisture in the skin
Aminoácidos de efecto cosmético o dermatológico particularmente ventajoso son la glicina, alanina, valina, leucina, isoleucina, fenilalanina, tirosina, prolina, hidroxiprolina, serina, treonina, cisteína, metionina, triptófano, arginina.Amino acids of cosmetic or dermatological effect Particularly advantageous are glycine, alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, proline, hydroxyproline, serine, Threonine, cysteine, methionine, tryptophan, arginine.
(3) Ácidos \alpha-hidroxicarboxílicos, \alpha-cetocarboxílicos y \beta-hidroxicarboxílicos cosmética o dermatológicamente relevantes, y sobre todo sus sales, cuyos cationes pueden seleccionarse del grupo constituido por iones amonio, alquilamonio, de metal alcalino, de metal alcalino-térreo, magnesio, hierro y cinc.(3) Acids α-hydroxycarboxylic acids, α-ketocarboxylic and cosmetic? -hydroxycarboxylic or dermatologically relevant, and especially its salts, whose cations can be selected from the group consisting of ions ammonium, alkylammonium, alkali metal, metal alkaline earth, magnesium, iron and zinc.
\newpage\ newpage
Los ácidos \alpha-hidroxicarboxílicos cosmética o dermatológicamente relevantes siguen la fórmula generalAcids cosmetic α-hydroxycarboxylic or dermatologically relevant follow the general formula
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Los ácidos \beta-hidroxicarboxílicos cosmética o dermatológicamente relevantes siguen la fórmula generalAcids cosmetic? -hydroxycarboxylic or dermatologically relevant follow the general formula
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Los ácidos \alpha-cetocarboxílicos cosmética o dermatológicamente relevantes siguen la fórmula generalAcids α-ketocarboxylic cosmetics or dermatologically relevant follow the general formula
donde R' y R'' se eligen respectiva e independientemente entre sí de los siguientes grupos (a) hasta (e)where R 'and R' 'are chosen respectively and independently of each other from the following groups (a) until (and)
(a) H-,(a) H-,
(b) alquilo C_{1-25}-ramificado o lineal,(b) alkyl C_ {1-25} -branched or linear,
(c) alquilo C_{1-25}-ramificado o lineal sustituido con uno o más grupos carboxilo y/o hidroxilo y/o aldehído y/u oxo (grupos cetónicos),(c) alkyl C_ {1-25} -branched or linear substituted with one or more carboxyl and / or hydroxyl and / or aldehyde groups and / or oxo (ketone groups),
(d) fenilo-,(d) phenyl-,
(e) fenilo-sustituido con uno o más grupos carboxilo y/o hidroxilo y/o alquilo C_{1-25} ramificado y/o lineal, o bien formando el átomo de carbono \alpha y el átomo de carbono \beta del ácido \beta-hidroxicarboxílico junto con R' y R''(e) phenyl-substituted with one or more carboxyl and / or hydroxyl and / or alkyl groups C 1-25 branched and / or linear, or forming the α-carbon atom and the β-carbon atom of the acid β-hydroxycarboxylic together with R 'and R' '
(f) un grupo cicloalquilo o arilo no sustituido, con un anillo de 3 hasta 7 átomos, o(f) a cycloalkyl or aryl group not substituted, with a ring of 3 to 7 atoms, or
(g) un grupo cicloalquilo o arilo, con un anillo de 3 a 7 átomos, sustituido con uno o más grupos carboxilo y/o hidroxilo y/u oxo (grupos cetónicos) y/o alquilo C_{1-25} ramificado y/o lineal,(g) a cycloalkyl or aryl group, with a ring of 3 to 7 atoms, substituted with one or more carboxyl groups and / or hydroxyl and / or oxo (ketone groups) and / or alkyl C 1-25 branched and / or linear,
y donde los ácidos \alpha-hidroxicarboxílicos o \beta-hidroxi-carboxílicos o \alpha-cetocarboxílicos pueden hallarse en forma de sus sales fisiológicamente compatibles.and where acids α-hydroxycarboxylic or β-hydroxycarboxylic or α-ketocarboxylic acids can be in the form of its physiologically compatible salts.
Los ácidos \alpha-hidroxicarboxílicos, \beta-hidroxicarboxílicos y \alpha-cetocarboxílicos usados según la presente invención se eligen ventajosamente de las siguientes clases de sustancias, las cuales también se enumeran en representación de sus sales o aniones:Acids α-hydroxycarboxylic acids, β-hydroxycarboxylic and α-ketocarboxylic used according to the present invention are advantageously chosen from the following kinds of substances, which are also listed on behalf of their salts or anions:
Ácido salicílico (también ácido 2-hidroxibenzoico, ácido espírico), caracterizado por la estructuraSalicylic acid (also acidic 2-hydroxybenzoic, spiric acid), characterized by the structure
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Como es sabido el ácido salicílico tiene acción antibacteriana y queratolítica y forma parte de algunos preparados cosméticos o farmacéuticos.As is known, salicylic acid has an action antibacterial and keratolytic and is part of some preparations Cosmetics or pharmaceuticals.
\newpage\ newpage
Los ácidos \alpha-hidroxicarboxílicos usados según la presente invención se eligen ventajosamente de las siguientes clases de sustancias (h) hasta (k):Acids α-hydroxycarboxylic acids used according to The present invention is advantageously chosen from the following classes of substances (h) to (k):
(h) ácidos grasos \alpha-hidroxilados, que a su vez se eligen ventajosamente del grupo de los ácidos alquil-C_{10-18}-carboxílicos,(h) fatty acids α-hydroxylates, which in turn are chosen advantageously of the acid group C10-18 alkylcarboxylic acids,
(i) ácidos \alpha-hidroxisacáricos y ácidos \alpha-hidroxifrutales alifáticos,(i) acids α-hydroxysaccharics and acids aliphatic α-hydroxyfrutals,
(j) ácidos \alpha-hidroxicarboxílicos aromáticos no sustituidos (p. ej. ácido mandélico) o(j) acids non-aromatic α-hydroxycarboxylic acids substituted (eg mandelic acid) or
(k) ácidos \alpha-hidroxicarboxílicos aromáticos sustituidos.(k) acids aromatic α-hydroxycarboxylic acids replaced.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Los ácidos grasos \alpha-hidroxilados del punto (h) se eligen muy ventajosamente del grupo de losFatty acids α-hydroxylates of point (h) are chosen very advantageously of the group of
- ácidos \alpha-hidroxicarboxílicos según la fórmula- acids α-hydroxycarboxylic according to the formula
y/oI
- ácidos \alpha-hidroxi-isocarboxílicos según la fórmula- acids α-hydroxy-isocarboxylic according to the formula
y/oI
- ácidos \alpha-hidroxi-anteisocarboxílicos según la fórmula- acids α-hydroxy-anteisocarboxylic according to the formula
donde n es respectivamente un número desde 7 hasta 31.where n is respectively a number from 7 to 31.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
También pueden emplearse ventajosamente mezclas de tales ácidos \alpha-hidroxicarboxílicos alifáticos, sobre todo en forma de mezclas de ácidos lanolínicos cuyo contenido de \alpha-hidroxi-carboxílicos es del 20-30% en peso respecto a la composición total de la mezcla.Mixtures may also be advantageously used. of such α-hydroxycarboxylic acids aliphatic, especially in the form of mixtures of lanolinic acids whose content of α-hydroxycarboxylic is from 20-30% by weight with respect to the total composition of the mixture.
Los ácidos \alpha-hidroxisacáricos del punto (i) se escogen muy ventajosamente del grupo de losAcids α-hydroxysaccharics of item (i) are chosen very advantageously of the group of
- --
- ácidos aldónicos, p. ej. ácido glucónico, ácido galactónicoacids aldonic, p. ex. gluconic acid, galactonic acid
- --
- ácidos aldáricos, p. ej. ácido glucárico, ácido galactárico (pero también el ácido frutal tartárico, que cae asimismo dentro de la definición de ácidos aldáricos) aldaric acids, e.g. ex. glucaric acid, galactaric acid (but also tartaric fruit acid, which also falls within the definition of aldaric acids)
- --
- ácidos urónicos, p. ej. ácido glucurónico, ácido galacturónicoacids uronic, p. ex. glucuronic acid, galacturonic acid
- --
- ácido glicéricoacid glyceric
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Los ácidos \alpha-hidroxifrutales del punto (i) se eligen muy ventajosamente del grupo constituido por los ácidos málico, láctico, cítrico, tartárico.Acids α-hydroxyfrutals of point (i) are chosen very advantageously of the group consisting of malic, lactic acids, citrus, tartaric.
El ácido málico (hidroxisuccínico) se caracteriza por la siguiente estructura química:Malic acid (hydroxysuccinic) is characterized by the following chemical structure:
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
El ácido láctico (2-hidroxipropanoico) se caracteriza por la siguiente estructura química:Lactic acid (2-hydroxypropanoic acid) is characterized by the following chemical structure:
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
El ácido cítrico (2-hidroxi-1,2,3-propanotrioico) se caracteriza por la siguiente estructura química:Citric acid (2-hydroxy-1,2,3-propanotrioic) It is characterized by the following chemical structure:
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Como es sabido el ácido cítrico se emplea para tamponar preparados cosméticos y/o dermatológicos, pero también como agente sinérgico para los antioxidantes en la cosmética de la piel y el cabello.As is known, citric acid is used to buffer cosmetic and / or dermatological preparations, but also as synergistic agent for antioxidants in skin cosmetics and The hair.
El ácido tartárico (dihidroxisuccínico) se caracteriza por la siguiente estructura química:Tartaric acid (dihydroxysuccinic) is characterized by the following chemical structure:
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Como ácido \alpha-cetocarboxílico se prefiere el ácido pirúvico (\alpha-oxopropanoico), que se caracteriza por la siguiente estructura:As acid α-ketocarboxylic acid is preferred pyruvic (α-oxopropanoic), which characterized by the following structure:
La cantidad máxima de electrolitos utilizables depende en última instancia de su solubilidad en la fase acuosa. La presente invención establece básicamente modelos, pero ningún tope de cantidad máxima, ya que por cualquier motivo incluso puede resultar ventajosa la incorporación a un preparado cosmético o dermatológico de una cantidad adicional de electrolito superior a su solubilidad, por ejemplo como sólido no disuelto.The maximum amount of usable electrolytes it ultimately depends on its solubility in the aqueous phase. The The present invention basically establishes models, but no ceilings of maximum amount, because for any reason you can even it is advantageous to incorporate a cosmetic preparation or dermatological of an additional amount of electrolyte greater than its solubility, for example as an undissolved solid.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
La fase orgánica de las emulsiones W/O según la presente invención se escoge ventajosamente del grupo de las lecitinas y de los triglicéridos de ácido graso, concretamente de los triglicerinésteres de ácidos alcanocarboxílicos saturados y/o insaturados, ramificados y/o lineales, con una longitud de cadena de 8 hasta 24, especialmente 12 hasta 18 átomos de C. Los triglicéridos de ácido graso se pueden elegir ventajosamente, por ejemplo, del grupo de aceites sintéticos, semisintéticos y naturales, como p. ej. los de oliva, girasol, soja, cacahuete, colza, almendra, palma, coco, ricino, germen de trigo, pepita de uva, cardo, onagra y otros análogos.The organic phase of the W / O emulsions according to the The present invention is advantageously chosen from the group of lecithins and fatty acid triglycerides, specifically of triglycerinesters of saturated alkanocarboxylic acids and / or unsaturated, branched and / or linear, with a chain length of 8 to 24, especially 12 to 18 C atoms. fatty acid triglycerides can be chosen advantageously, by example, from the group of synthetic, semi-synthetic and natural, such as p. ex. those of olive, sunflower, soy, peanut, rapeseed, almond, palm, coconut, castor, wheat germ, nugget Grape, thistle, evening primrose and other analogues.
En la presente invención, los aceites también se eligen ventajosamente del grupo formado por vaselina (petrolato), aceite de parafina y poliolefinas. Las sustancias preferidas entre las poliolefinas son los polidecenos.In the present invention, oils are also advantageously choose from the group consisting of petroleum jelly (petrolatum), paraffin oil and polyolefins. Preferred substances among Polyolefins are polydecenes.
Según la presente invención la fase orgánica también se puede escoger ventajosamente del grupo de los ésteres de los ácidos alcanocarboxílicos saturados y/o insaturados, ramificados y/o lineales de 3 hasta 30 átomos de C de longitud de cadena con alcoholes saturados y/o insaturados, ramificados y/o lineales de 3 hasta 30 átomos de C de longitud de cadena, así como del grupo de los ésteres de los ácidos carboxílicos aromáticos con alcoholes saturados y/o insaturados, ramificados y/o lineales de 3 a 30 átomos de C de longitud de cadena. Estos aceites estéricos pueden escogerse convenientemente del grupo formado por miristato de isopropilo, palmitato de isopropilo, estearato de isopropilo, oleato de isopropilo, estearato de n-butilo, laurato de n-hexilo, oleato de n-decilo, estearato de isooctilo, estearato de isononilo, isononanoato de isononilo, palmitato de 2-etilhexilo, laurato de 2-etil-hexilo, estearato de 2-hexildecilo, palmitato de 2-octil-dodecilo, heptanoato de estearilo, oleato de oleílo, erucato de oleílo, oleato de erucilo, erucato de erucilo, así como mezclas sintéticas, semisintéticas y naturales de los citados ésteres, como p. ej. el aceite de jojoba.According to the present invention the organic phase it can also be advantageously chosen from the group of esters of saturated and / or unsaturated, branched alkanocarboxylic acids and / or linear 3 to 30 C atoms of chain length with saturated and / or unsaturated, branched and / or linear alcohols of 3 up to 30 C atoms of chain length, as well as the group of esters of aromatic carboxylic acids with alcohols saturated and / or unsaturated, branched and / or linear from 3 to 30 atoms of C chain length. These steric oils can choose conveniently from the group consisting of myristate of isopropyl, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, laurate of n-hexyl, n-decyl oleate, isooctyl stearate, isononyl stearate, isononanoate isononyl, 2-ethylhexyl palmitate, laurate 2-ethyl-hexyl stearate 2-hexyldecyl palmitate 2-octyl dodecyl heptane stearyl, oleyl oleate, oily erucate, erucilo oleate, belching erucate, as well as synthetic, semi-synthetic and natural esters of said esters, such as p. ex. the oil of jojoba
Además la fase orgánica se puede escoger ventajosamente del grupo de los hidrocarburos y de las ceras de hidrocarburo ramificadas y lineales, de los aceites de silicona, de los dialquiléteres, del grupo de los alcoholes saturados o insaturados, ramificados o lineales.In addition the organic phase can be chosen advantageously of the group of hydrocarbons and waxes of branched and linear hydrocarbon, of silicone oils, of dialkyl ethers, from the group of saturated alcohols or unsaturated, branched or linear.
Según la presente invención también puede emplearse ventajosamente cualquier mezcla de dichos componentes oleosos y céreos. Dado el caso, también puede resultar ventajoso el uso de ceras, por ejemplo palmitato de cetilo, como único componente lípido de la fase orgánica.According to the present invention it can also any mixture of said components is advantageously used Oily and waxy. If necessary, it may also be advantageous to use of waxes, for example cetyl palmitate, as the sole component lipid of the organic phase.
Entre los hidrocarburos puede utilizarse ventajosamente, según la presente invención, aceite de parafina, escualano y escualeno.Among the hydrocarbons can be used advantageously, according to the present invention, paraffin oil, Squalane and Squalane.
Asimismo la fase orgánica puede contener ventajosamente aceites de silicona cíclicos o lineales o constar totalmente de ellos, aunque de todos modos es preferible que, además del aceite o aceites de silicona, lleve un contenido adicional de otros componentes oleosos.Also the organic phase may contain advantageously cyclic or linear silicone oils or consist totally of them, although anyway it is preferable that, in addition of silicone oil or oils, carry an additional content of Other oil components.
Como aceite de silicona se utiliza ventajosamente según la presente invención la ciclometicona (octametilciclotetrasiloxano). Pero según la presente invención también puede ser ventajoso el empleo de otros aceites de silicona, por ejemplo hexametilciclotrisiloxano, polidimetilsiloxano, poli(metil-fenilsiloxano).How silicone oil is used advantageously according to the present invention cyclomethicone (octamethylcyclotetrasiloxane). But according to the present invention the use of other silicone oils may also be advantageous, for example hexamethylcyclotrisiloxane, polydimethylsiloxane, poly (methyl-phenylsiloxane).
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
La fase acuosa de los preparados de la presente invención contiene ventajosamente, dado el caso, alcoholes, dioles o polioles de bajo número de C, así como sus éteres, preferiblemente etanol, isopropanol, propilenglicol, glicerina, etilenglicol, etilenglicolmonoetil- o -monobutiléter, propilenglicolmonometil-, -monoetil- o -monobutiléter, dietilenglicolmonometil- o -monoetiléter y productos similares; también alcoholes de bajo número de C, p. ej. etanol, isopropanol, 1,2-propanodiol, glicerina, así como especialmente uno o más espesantes, que pueden elegirse ventajosamente del grupo formado por dióxido de silicio, silicatos de aluminio, polisacáridos y sus derivados, p. ej. ácido hialurónico, goma xantana, hidroxipropilmetilcelulosa, y de manera especialmente ventajosa del grupo de los poliacrilatos, preferentemente un poli-acrilato del grupo de los denominados Carbopoles, por ejemplo Carbopoles de los tipos 980, 981, 1382, 2984, 5984, o bien de los tipos ETD (Easy-to-disperse [fácilmente dispersables]), ya sea solos en cualquier combinación entre sí.The aqueous phase of the preparations of the present invention advantageously contains, where appropriate, alcohols, diols or polyols of low C number, as well as their ethers, preferably ethanol, isopropanol, propylene glycol, glycerin, ethylene glycol, ethylene glycol monoethyl- or -butyl ether, propylene glycol monomethyl-, -monoethyl- or -monobutylether, diethylene glycolmonomethyl- or -monoethyl ether and similar products; also alcohols of low C number, p. ex. ethanol, isopropanol, 1,2-propanediol, glycerin, as well as especially one or more thickeners, which can be advantageously chosen from the group consisting of silicon dioxide, aluminum silicates, polysaccharides and their derivatives, e.g. ex. hyaluronic acid, xanthan gum, hydroxypropylmethylcellulose, and especially advantageously of the polyacrylate group, preferably a poly-acrylate of the group of so-called Carbopoles, for example Carbopoles of the types 980, 981, 1382, 2984, 5984, or ETD types (Easy-to-disperse [ easily dispersible ]), either alone in any combination with each other.
También se obtienen preparados especialmente ventajosos utilizando antioxidantes como aditivos o principios activos. Según la presente invención, los preparados llevan ventajosamente uno o más antioxidantes. Como antioxidantes propicios, aunque facultativos, se pueden emplear todos aquellos que son apropiados o habituales para las aplicaciones cosméticas y/o dermatológicas.Special preparations are also obtained. advantageous using antioxidants as additives or principles assets. According to the present invention, the preparations carry advantageously one or more antioxidants. As antioxidants propitious, although optional, all those who are appropriate or usual for cosmetic applications and / or dermatological
Los antioxidantes se escogen ventajosamente del grupo formado por aminoácidos (p. ej. glicina, histidina, tirosina, triptófano) y sus derivados, imidazoles (p. ej. ácido urocanínico) y sus derivados, péptidos como D,L-carnosina, D-carno-sina, L-carnosina y sus derivados (p. ej. anserina), carotinoides, carotenos (p. ej. \alpha-caroteno, \beta-caroteno, licopina) y sus derivados, ácido lipónico y sus derivados (p. ej. ácido dihidrolipónico), aurotioglucosa, propiltiouracilo y otros tioles (p. ej. tiorredoxina, glutatión, cisteína, cistina, cistamina y sus ésteres de glicosilo, N-acetilo, metilo, etilo, propilo, amilo, butilo y laurilo, palmitoílo, oleílo, \gamma-linoleílo, colesterilo y glicerilo) así como sus sales, tiodipropionato de dilaurilo, tiodipropionato de diestearilo, ácido tiodipropiónico y sus derivados (ésteres, éteres, péptidos, lípidos, nucleótidos, nucleósidos y sales), así como compuestos de sulfoximina (p. ej. butioninsulfoximina, homocisteínsulfoximina, butioninsulfonas, penta-, hexa-, heptationinsulfoximina) en dosificaciones compatibles muy bajas (p. ej. de pmol hasta \mumol/kg), también quelantes (de metales) (p. ej. ácidos grasos \alpha-hidroxilados, ácido palmítico, ácido fitínico, lactoferrina), ácidos \alpha-hidroxilados (p. ej. ácido cítrico, ácido láctico, ácido málico), ácido húmico, ácido biliar, extractos biliares, bilirrubina, biliverdina, EDTA, EGTA y sus derivados, ácidos grasos insaturados y sus derivados (p. ej. ácido \gamma-linolénico, ácido linólico, ácido oleico), ácido fólico y sus derivados, ubiquinona y ubiquinol y sus derivados, vitamina C y derivados (p. ej. palmitato de ascorbilo, fosfato de ascorbil-Mg, acetato de ascorbilo), tocoferoles y derivados (p. ej. acetato de vitamina E), vitamina A y derivados (palmitato de vitamina A), así como el benzoato de coniferilo del benjuí, ácido rutínico y sus derivados, ácido ferúlico y sus derivados, butilhidroxitolueno, butilhidroxi-anisol, ácido nordihidroguayacónico, ácido nordihidroguayarético, trihidroxibutirofenona, ácido úrico y sus derivados, manosa y sus derivados, cinc y sus derivados (p. ej. ZnO, ZnSO_{4}), selenio y sus derivados (p. ej. selenio-metionina), estilbeno y sus derivados (p. ej. óxido de estilbeno, óxido de trans-estilbeno) y los derivados idóneos según la presente invención (sales, ésteres, éteres, azúcares, nucleótidos, nucleósidos, péptidos y lípidos) de dichos principios activos.Antioxidants are advantageously chosen from group consisting of amino acids (eg glycine, histidine, tyrosine, tryptophan) and its derivatives, imidazoles (eg urocaninic acid) and its derivatives, peptides such as D, L-carnosine, D-carno-sina, L-carnosine and its derivatives (eg anserine), carotinoids, carotenes (eg? -carotene, β-carotene, lycopene) and its derivatives, acid liponic and its derivatives (eg dihydroliponic acid), aurothioglucose, propylthiouracil and other thiols (e.g. thioredoxin, glutathione, cysteine, cystine, cystamine and its esters of glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, γ-linoleyl, cholesteryl and glyceryl) as well as its salts, dilauryl thiodipropionate, thiodipropionate distearyl, thiodipropionic acid and its derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts), as well as sulfoximin compounds (eg butioninsulfoximin, homocysteinesulfoximin, butioninsulfones, penta-, hexa-, heptationinsulfoximin) in very low compatible dosages (e.g. ex. from pmol to umol / kg), also chelants (from metals) (p. ex. α-hydroxylated fatty acids, acid palmitic acid, phytinic acid, lactoferrin), acids α-hydroxylates (eg citric acid, acid lactic acid, malic acid), humic acid, bile acid, extracts bile, bilirubin, biliverdin, EDTA, EGTA and its derivatives, unsaturated fatty acids and their derivatives (eg acid γ-linolenic, linolic acid, oleic acid), folic acid and its derivatives, ubiquinone and ubiquinol and their derivatives, vitamin C and derivatives (eg ascorbyl palmitate, ascorbyl-phosphate, ascorbyl acetate), tocopherols and derivatives (eg vitamin E acetate), vitamin A and derivatives (vitamin A palmitate), as well as benzoate benzoin coniferyl, rutinic acid and its derivatives, acid ferulic acid and its derivatives, butylhydroxytoluene, butylhydroxy-anisole, nordihydroguayaconic acid, nordihydroguayretic acid, trihydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, zinc and its derivatives (e.g. ZnO, ZnSO4), selenium and its derivatives (e.g. selenium-methionine), stilbene and its derivatives (e.g. ex. stilbene oxide, trans-stilbene oxide) and the suitable derivatives according to the present invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these active principles.
De manera especialmente ventajosa según la presente invención se pueden usar antioxidantes liposolubles.Especially advantageous according to the present invention fat soluble antioxidants can be used.
Una propiedad asombrosa de los preparados de la presente invención es que constituyen un vehículo muy bueno para la penetración en la piel de los principios activos cosméticos o dermatológicos, prefiriéndose como tales los antioxidantes capaces de proteger la piel contra las agresiones oxidantes. En este caso los antioxidantes preferidos son la vitamina E y sus derivados, así como la vitamina A y sus derivados.An amazing property of the preparations of the present invention is that they constitute a very good vehicle for the skin penetration of cosmetic active ingredients or dermatological, with antioxidants being preferred as such to protect the skin against oxidative aggressions. In this case Preferred antioxidants are vitamin E and its derivatives, as well like vitamin A and its derivatives.
La cantidad de antioxidantes (uno o varios compuestos) en los preparados es preferiblemente de 0,001 hasta 30% en peso, con especial preferencia 0,05-20% en peso, sobre todo de 1-10% en peso, referido al peso total del preparado.The amount of antioxidants (one or several compounds) in the preparations is preferably from 0.001 to 30% by weight, especially 0.05-20% by weight, especially 1-10% by weight, based on total weight of the preparation
Siempre que el o los antioxidantes sean de vitamina E y/o de sus derivados conviene que sus respectivas concentraciones estén comprendidas en el intervalo del 0,001-10% en peso, referido al peso total de la formulación.Provided that the antioxidant (s) are Vitamin E and / or its derivatives should be their respective concentrations are in the range of 0.001-10% by weight, based on the total weight of the formulation.
Siempre que el o los antioxidantes sean de vitamina A o de sus derivados, o de caroteno o de sus derivados, conviene que sus respectivas concentraciones estén comprendidas en el intervalo del 0,001-10% en peso, referido al peso total de la formulación.Provided that the antioxidant (s) are vitamin A or its derivatives, or carotene or its derivatives, it is appropriate that their respective concentrations be included in the range of 0.001-10% by weight, based on weight Total formulation.
Naturalmente el especialista ya sabe que en la mayoría de los casos los preparados cosméticos son inimaginables sin las sustancias auxiliares y los aditivos usuales. Por tanto los preparados cosméticos y dermatológicos de la presente invención también pueden llevar componentes auxiliares normalmente empleados en cosmética, por ejemplo aditivos para dar consistencia, estabilizantes, cargas, conservantes, perfumes, antiespumantes, colorantes, pigmentos, espesantes, sustancias tensioactivas, emulsionantes, agentes emolientes, hidratantes y/o humectantes, sustancias antiinflamatorias, otros principios activos como vitaminas o proteínas, agentes fotoprotectores, repelentes de insectos, bactericidas, virucidas, agua, sales, sustancias de acción antimicrobiana, proteolítica o queratolítica, medicamentos u otros ingredientes usuales en una formulación cosmética o dermatológica, como alcoholes, polioles, polímeros, estabilizadores de espuma, disolventes orgánicos o también otros electrolitos.Naturally the specialist already knows that in the most cases cosmetic preparations are unimaginable without the auxiliary substances and the usual additives. Therefore the cosmetic and dermatological preparations of the present invention they can also carry normally used auxiliary components in cosmetics, for example additives to give consistency, stabilizers, fillers, preservatives, perfumes, defoamers, dyes, pigments, thickeners, surfactants, emulsifiers, emollient agents, moisturizers and / or humectants, anti-inflammatory substances, other active ingredients such as vitamins or proteins, photoprotective agents, repellents of insects, bactericides, virucidal, water, salts, substances of action antimicrobial, proteolytic or keratolytic, medications or other usual ingredients in a cosmetic or dermatological formulation, such as alcohols, polyols, polymers, foam stabilizers, organic solvents or other electrolytes.
Estos últimos pueden elegirse, por ejemplo, del grupo de sales con los siguientes aniones: cloruros, también aniones inorgánicos Oxo-Elemento, entre ellos, sobre todo, sulfatos, carbonatos, fosfatos, boratos y aluminatos. Asimismo son ventajosos los electrolitos basados en aniones orgánicos, como p. ej. lactatos, acetatos, benzoatos, propionatos, tartratos, citratos, aminoácidos, ácido etilendiaminotetraacético y sus sales y otros más. Como cationes de las sales se prefieren los iones amonio, alquilamonio, de metal alcalino, de metal alcalinotérreo, magnesio, hierro y cinc. No hace falta decir que en cosmética solo deben usarse electrolitos fisiológicamente inocuos. Se prefiere sobre todo el cloruro potásico, el cloruro sódico, el sulfato magnésico, el sulfato de cinc y las mezclas de los mismos.The latter can be chosen, for example, from group of salts with the following anions: chlorides, also Oxo-Element inorganic anions, including all, sulfates, carbonates, phosphates, borates and aluminates. Anion-based electrolytes are also advantageous organic, such as p. ex. lactates, acetates, benzoates, propionates, tartrates, citrates, amino acids, ethylenediaminetetraacetic acid and Your salts and others. As cations of the salts, the ammonium, alkylammonium, alkali metal, metal ions alkaline earth, magnesium, iron and zinc. Needless to say, in Only physiologically safe electrolytes should be used. Especially preferred is potassium chloride, sodium chloride, magnesium sulfate, zinc sulfate and mixtures of same.
Mutatis mutandis valen los mismos requerimientos para los preparados medicinales. Mutatis mutandis are worth the same requirements for medicinal preparations.
Las emulsiones W/O según la presente invención pueden ser la base de formulaciones cosméticas o dermatológicas que pueden tener la composición usual y servir, por ejemplo, para el tratamiento y cuidado de la piel y/o del cabello, como protector labial, como desodorante y como producto de maquillaje y desmaquillaje en cosmética decorativa, o como preparado fotoprotector. Para su uso, los preparados cosméticos y dermatológicos de la presente invención se aplican en cantidad suficiente sobre la piel y/o el cabello, tal como se hace habitualmente con los productos cosméticos.W / O emulsions according to the present invention they can be the basis of cosmetic or dermatological formulations that they can have the usual composition and serve, for example, for treatment and care of the skin and / or hair, as a protector lipstick, as a deodorant and as a makeup product and makeup removal in decorative cosmetics, or as prepared photoprotector For use, cosmetic preparations and Dermatological of the present invention are applied in quantity enough on the skin and / or hair, as it is done usually with cosmetic products.
Según su composición las correspondientes formulaciones cosméticas o dermatológicas de uso tópico conforme a la presente invención se pueden utilizar, por ejemplo, como crema de protección cutánea, leche limpiadora, loción de protección solar, crema nutritiva, crema diurna o nocturna, etc. Dado el caso, también es posible y ventajoso el uso de las composiciones de la presente invención como base para formulaciones farmacéuticas.According to their composition the corresponding cosmetic or dermatological formulations for topical use according to the present invention can be used, for example, as a cream of skin protection, cleansing milk, sunscreen lotion, nourishing cream, day or night cream, etc. If necessary, also It is possible and advantageous to use the compositions herein invention as a basis for pharmaceutical formulations.
Los productos cosméticos o dermatológicos de baja viscosidad según la presente invención pueden estar en forma de preparados pulverizables mediante recipientes de aerosol, frascos exprimibles o dispositivos de bombeo, o en forma de una composición líquida aplicable con dispositivos de bola, pero también como una emulsión aplicable envasada en frascos y recipientes normales.The cosmetic or dermatological products of low viscosity according to the present invention may be in shape of sprays prepared by aerosol containers, bottles squeezers or pumping devices, or in the form of a composition liquid applicable with ball devices, but also as a Applicable emulsion packaged in normal bottles and containers.
Para pulverizar las composiciones cosméticas o dermatológicas según la presente invención mediante recipientes de aerosol son adecuados los propelentes muy volátiles licuados, normalmente conocidos, por ejemplo hidrocarburos (propano, butano, isobutano), que pueden usarse solos o mezclados entre sí. También puede emplearse ventajosamente aire comprimido.To spray the cosmetic compositions or dermatological according to the present invention by means of containers of aerosol are suitable highly volatile liquefied propellants, normally known, for example hydrocarbons (propane, butane, isobutane), which can be used alone or mixed together. Too compressed air can be used advantageously.
Naturalmente el especialista sabe que hay gases propelentes básicamente idóneos para la ejecución de la presente invención en forma de preparados del tipo aerosol, pero de los cuales debe prescindirse por su efecto perjudicial en el medio ambiente o por otras circunstancias, en concreto los hidrocarburos fluorocarbonados o fluoroclorocarbonados (CFC).Naturally the specialist knows that there are gases basically suitable propellants for the execution of this invention in the form of aerosol preparations, but of the which should be dispensed with for its harmful effect on the environment environment or for other circumstances, specifically hydrocarbons fluorocarbons or fluorochlorocarbons (CFC).
También resultan ventajosos los preparados cosméticos y dermatológicos en forma de protectores solares, los cuales, además de las combinaciones de principios activos de la presente invención, contienen al menos una sustancia filtrante de UV-A y/o al menos una sustancia filtrante de UV-B y/o al menos un pigmento inorgánico.The preparations are also advantageous Cosmetic and dermatological in the form of sunscreens, which, in addition to the combinations of active ingredients of the present invention, contain at least one filter substance of UV-A and / or at least one filter substance of UV-B and / or at least one inorganic pigment.
No obstante según la presente invención también es ventajosa la elaboración de preparados cosméticos y dermatológicos cuya finalidad principal no es la protección contra la luz solar, aunque lleven sustancias protectoras del UV. Así, p. ej., suelen incorporarse sustancias filtrantes de UV-A o de UV-B a las cremas de día. Las sustancias protectoras de UV, al igual que los antioxidantes y opcionalmente los conservantes, protegen efectivamente los preparados contra la putrefacción.However according to the present invention also It is advantageous to prepare cosmetic preparations and dermatological whose main purpose is not protection against sunlight, even if they carry UV protective substances. So, p. For example, filter substances of UV-A or UV-B to day creams. UV protective substances, as well as antioxidants and optionally preservatives, effectively protect prepared against rot.
Además los preparados de la presente invención pueden llevar ventajosamente sustancias que absorben la radiación UV en la región UV-B, de modo que la cantidad total de sustancias filtrantes sea, p. ej., del 0,1% en peso al 30% en peso, con preferencia del 0,5 al 10% en peso, sobre todo del 1,0 al 6,0% en peso, respecto al peso total de los preparados, para proporcionar preparados cosméticos que protejan el cabello o la piel contra todo el espectro de la radiación ultravioleta. También pueden servir de protectores solares para el cabello o la piel.In addition the preparations of the present invention they can advantageously carry radiation absorbing substances UV in the UV-B region, so that the total amount of filtering substances, e.g. for example, from 0.1% by weight to 30% in weight, preferably 0.5 to 10% by weight, especially 1.0 to 10 6.0% by weight, based on the total weight of the preparations, for provide cosmetic preparations that protect hair or skin against the entire spectrum of ultraviolet radiation. Too They can serve as sunscreens for hair or skin.
Cuando las emulsiones de la presente invención
contienen sustancias filtrantes de UV-B, éstas
pueden ser liposolubles o hidrosolubles. Como sustancias filtrantes
de UV-B liposolubles son ventajosas según la
presente invención
p. ej.:When the emulsions of the present invention contain UV-B filter substances, they can be fat-soluble or water-soluble. As fat-soluble UV-B filter substances are advantageous according to the present invention.
p. ex .:
- --
- los derivados del 3-bencilidenalcanfor, preferiblemente 3-(4-metilbenciliden)alcanfor, 3-benciliden-alcanfor;the 3-benzylidene camphor derivatives, preferably 3- (4-methylbenzylidene) camphor, 3-benzylidene-camphor;
- --
- los derivados de ácido 4-aminobenzoico, preferiblemente 4-(dimetilamino)-benzoato de 2-etilhexilo, 4-(dimetilamino)-benzoato de amilo;the 4-aminobenzoic acid derivatives, preferably 4- (dimethylamino) -benzoate 2-ethylhexyl, 4- (dimethylamino) -amyl benzoate;
- --
- los ésteres del ácido cinámico, preferiblemente 4-metoxicinamato de 2-etilhexilo, 4-metoxicinamato de isopentilo;the esters of cinnamic acid, preferably 2-ethylhexyl 4-methoxycinnamate, Isopentyl 4-methoxycinnamate;
- --
- los ésteres del ácido salicílico, preferiblemente salicilato de 2-etilhexilo, salicilato de 4-isopropil-bencilo, salicilato de homomentilo;the esters of salicylic acid, preferably salicylate of 2-ethylhexyl salicylate 4-isopropyl benzyl salicylate homomentyl;
- --
- los derivados de la benzofenona, preferiblemente 2-hidroxi-4-metoxibenzofenona, 2-hidroxi-4-metoxi-4'-metilbenzofenona, 2,2'-dihidroxi-4-metoxibenzofenona;the benzophenone derivatives, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
- --
- los ésteres del ácido benzalmalónico, preferiblemente 4-metoxibenzalmalonato de di(2-etilhexilo);the esters of benzalmalonic acid, preferably 4-methoxybenzalmalonate di (2-ethylhexyl);
- --
- 2,4,6-trianilino-(p-carbo-2'-etil-1'-hexiloxi)-1,3,5-triazina.2,4,6-Trianilino- (p-carbo-2'-ethyl-1'-hexyloxy) -1,3,5-triazine.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Naturalmente la lista de los citados filtros de UVB que pueden usarse en combinación con las mezclas de principios activos según la presente invención no debe ser excluyente.Naturally the list of the aforementioned filters of UVB that can be used in combination with the mixtures of principles assets according to the present invention should not be exclusive.
También puede resultar ventajoso formular las lipodispersiones de la presente invención con filtros UVA que hasta ahora suelen contener los preparados cosméticos. En el caso de estas sustancias se trata preferentemente de derivados del dibenzoílmetano, sobre todo de la 1-(4'-terc-butilfenil)-3-(4'-metoxifenil)propano-1,3-diona y de la 1-fenil-3-(4'-iso-propilfenil)propano-1,3-diona.It may also be advantageous to formulate the lipodispersions of the present invention with UVA filters that up to Now they usually contain cosmetic preparations. In the case of these substances are preferably derivatives of dibenzoylmethane, especially from the 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione and of the 1-phenyl-3- (4'-iso-propylphenyl) propane-1,3-dione.
Los preparados cosméticos y dermatológicos según la presente invención también pueden llevar pigmentos inorgánicos, que en cosmética suelen utilizarse para proteger la piel de los rayos UV. En este caso se trata de óxidos de titanio, cinc, hierro, circonio, silicio, manganeso, aluminio, cerio y mezclas de los mismos, así como de modificaciones en que los óxidos son los agentes activos. Con especial preferencia se trata de pigmentos basados en el dióxido de titanio.Cosmetic and dermatological preparations according to The present invention can also carry inorganic pigments, which in cosmetics are often used to protect the skin from UV rays. In this case it is titanium oxides, zinc, iron, Zirconium, silicon, manganese, aluminum, cerium and mixtures of themselves, as well as modifications in which the oxides are active agents. With special preference it is pigments based on titanium dioxide.
Como ingredientes adicionales pueden usarse:As additional ingredients can be used:
- --
- grasas, ceras y otras lípidos sólidos naturales y sintéticas, preferiblemente ésteres de ácidos grasos con alcoholes de bajo número de C, p. ej. con isopropanol, propilenglicol o glicerina, o ésteres de alcoholes grasos con ácidos alcanocarboxílicos de bajo número de C o con ácidos grasos;fats, waxes and other solid lipids natural and synthetic, preferably fatty acid esters with low C alcohols, p. ex. with isopropanol, propylene glycol or glycerin, or esters of fatty alcohols with acids alkanocarboxylic of low C number or with fatty acids;
- --
- alcoholes, dioles o polioles de bajo número de C, así como sus éteres, preferiblemente etanol, isopropanol, propilenglicol, glicerina, etilenglicol, etilenglicol-monoetil- o -monobutiléter, propilenglicolmonometil-, -monoetil- o -monobutiléter, dietilenglicolmonometil- o -monoetiléter y productos similares.low alcohols, diols or polyols C number, as well as its ethers, preferably ethanol, isopropanol, propylene glycol, glycerin, ethylene glycol, ethylene glycol monoethyl- or -butyl ether, propylene glycol monomethyl-, -monoethyl- or -monobutylether, diethylene glycol monomethyl- or -monoethyl ether and products Similar.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Los siguientes ejemplos sirven para ilustrar la presente invención, pero sin limitarla. En ellos los valores numéricos están indicados en porcentajes en peso respecto al peso total de los correspondientes preparados.The following examples serve to illustrate the present invention, but without limiting it. In them the values Numeric are indicated in percentages by weight with respect to weight Total of the corresponding preparations.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\newpage\ newpage
(Continuación) (Continuation)
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Claims (7)
- (1)(one)
- una fase orgánica que lleva uno o varios aceites, grasas y/o ceras,a organic phase that carries one or more oils, fats and / or waxes,
- (2)(2)
- una fase acuosa que lleva disueltos uno o varios electrolitos, siendo la fuerza iónica de la fase acuosa de 0,075 moles/l como mínimo, ya aqueous phase that has dissolved one or more electrolytes, the ionic strength of the aqueous phase of at least 0.075 mol / l, Y
- (3)(3)
- un sistema emulsionante, formado por al menos dos emulsionantes escogidos del grupo constituido por poligliceril-3-diisoestearato, poligliceril-2-polihidroxi-estearato, PEG-30-dipolihidroxiestearato,a emulsifying system, consisting of at least two emulsifiers chosen from the group consisting of polyglyceryl-3-diisoestearate, polyglyceryl-2-polyhydroxy stearate, PEG-30-dipolihydroxystearate,
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19742467 | 1997-09-26 | ||
| DE19742467 | 1997-09-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2339307T3 true ES2339307T3 (en) | 2010-05-18 |
Family
ID=7843677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES98118102T Expired - Lifetime ES2339307T3 (en) | 1997-09-26 | 1998-09-24 | LITTLE VISCOSE COSMETIC OR DERMATOLOGICAL PREPARATIONS OF THE WATER-IN-OIL TYPE. |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0904773B1 (en) |
| AT (1) | ATE460151T1 (en) |
| DE (1) | DE59814440D1 (en) |
| ES (1) | ES2339307T3 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19850768A1 (en) * | 1998-06-18 | 1999-12-23 | Beiersdorf Ag | Flowable preparations of emulsion type W / O with increased water content |
| DE19855153A1 (en) * | 1998-11-19 | 2000-05-25 | Beiersdorf Ag | Preparations of emulsion type W / O with increased water content containing cationic polymers |
| DE19950059A1 (en) * | 1999-10-16 | 2001-04-19 | Beiersdorf Ag | Cosmetic and dermatological sunscreen formulations in the nature of O / W macroemulsions or O / W microemulsions containing poly-sulfonated sunscreens |
| DE10049066A1 (en) * | 2000-10-04 | 2002-04-18 | Beiersdorf Ag | Preparations of emulsion type W / O with increased water content containing polyether polyester and at least one substance selected from the group of nonionic polymers |
| DE10333443A1 (en) | 2003-07-23 | 2005-02-10 | Goldschmidt Ag | Emulsifier for low-viscosity W / O emulsions based on partially crosslinked polyglycerol esters of polyhydroxystearic acid |
| DE102004002997A1 (en) * | 2004-01-19 | 2005-08-04 | Beiersdorf Ag | Low-viscosity W / O emulsions without O / W emulsifiers |
| DE102012212548A1 (en) * | 2012-07-18 | 2014-01-23 | Beiersdorf Ag | Latest cosmetic sunscreen spray |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5162378A (en) * | 1990-04-20 | 1992-11-10 | Revlon Consumer Products Corporation | Silicone containing water-in-oil microemulsions having increased salt content |
| DE4126969A1 (en) * | 1991-08-14 | 1993-02-18 | Benckiser Gmbh Joh A | PRESERVATIVE COSMETICS |
| FR2754176B1 (en) * | 1996-10-07 | 1999-12-10 | Roche Posay Lab Pharma | W / O EMULSION WITH HIGH ELECTROLYTE CONTENT AND THEIR USE IN DERMO-COSMETICS, PARTICULARLY FOR TREATING PHENOMENES OF IRRITATION AND / OR SENSITIVE SKIN |
| DE19643237A1 (en) * | 1996-10-19 | 1998-04-23 | Beiersdorf Ag | Cosmetic and dermatological pens with high water content |
-
1998
- 1998-09-24 EP EP98118102A patent/EP0904773B1/en not_active Expired - Lifetime
- 1998-09-24 AT AT98118102T patent/ATE460151T1/en not_active IP Right Cessation
- 1998-09-24 ES ES98118102T patent/ES2339307T3/en not_active Expired - Lifetime
- 1998-09-24 DE DE59814440T patent/DE59814440D1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0904773B1 (en) | 2010-03-10 |
| ATE460151T1 (en) | 2010-03-15 |
| EP0904773A2 (en) | 1999-03-31 |
| EP0904773A3 (en) | 2003-10-08 |
| DE59814440D1 (en) | 2010-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6503518B1 (en) | Reduced lipid flowable preparations | |
| ES2208900T3 (en) | COSMETIC OR PHARMACEUTICAL PREPARATIONS WITH LOWER SENSATION OF STICK. | |
| ES2244122T3 (en) | COSMETIC AND DERMATOLOGICAL PREPARATIONS CONTAINING CHITOSAN AND PHOSPHOLIPIDS. | |
| US20040037795A1 (en) | Cosmetic or dermatological oil/water emulsions with reduced lipid content | |
| ES2214611T3 (en) | COSMETIC OR DERMATOLOGICAL MICROEMULSION. | |
| ES2221751T3 (en) | SYSTEMS FINALLY DISPERSED OF THE TYPE OIL IN WATER AND WATER IN OIL, WITHOUT EMULSIONERS, CONTAINING BORO NITRIDE. | |
| ES2279592T3 (en) | FINALLY DISPERSED SYSTEMS OF THE WATER TYPE IN OIL WITHOUT EMULSIONERS. | |
| ES2251126T3 (en) | COSMETIC OR DERMATOLOGICAL COMPOSITION THAT CONSISTS OF CARNITINE AND / OR AN ACILCARNITINE AND AT LEAST AN ANTIOXIDANTS. | |
| ES2359525T3 (en) | COSMETIC FORMULA WITH GLUCOSIL GLYCERIDS AND POWDERED RAW MATERIALS. | |
| ES2282502T3 (en) | COSMETIC AND DERMATOLOGICAL PREPARATIONS TO RELIEF THE PRURITE. | |
| US20020146375A1 (en) | Cosmetic or pharmaceutical lecithin-containing gels or low viscosity lecithin-containing O/W microemulsions | |
| US20010012860A1 (en) | Preparation of the w/o emulsion type with an increased water content, additionally comprising one or more alkylmethicone copolyols and/or alkyldimethicone copolyols, and cationic polymers | |
| ES2259333T3 (en) | POOR COSMETIC AND DERMATOLOGICAL PREPARATIONS IN LIPIDS IN THE FORM OF EMULSIONS WATER OIL WITH CONTENT IN FATTY ACIDS. | |
| US7138128B2 (en) | Preparations of the W/O emulsion type with an increased water content, and comprising cationic polymers | |
| ES2258844T3 (en) | PREPARED FLUID EMULSION W / O TYPE WITH GREATER WATER CONTENT. | |
| US6962711B1 (en) | Cosmetic and dermatological preparations comprising increased electrolyte concentrations | |
| ES2296581T3 (en) | STABLE COMBINATIONS OF ACTIVE PRINCIPLES CONTAINING TENSIOACTIVE GLUCOSE DERIVATIVES AND SALICILIC ACID. | |
| ES2291459T3 (en) | O / W EMULSIONS IN THE FORM OF GEL CONTAINING HYDROCOLOIDS. | |
| JP2000026233A (en) | Preparation of w/o type emulsion containing increased water content by containing additionally one or more kinds of alkylmethicone copolyol and/or alkyldimethicone copolyol | |
| US6821934B1 (en) | Flowable preparations of the water-in-oil emulsion type having an increased water content | |
| ES2339307T3 (en) | LITTLE VISCOSE COSMETIC OR DERMATOLOGICAL PREPARATIONS OF THE WATER-IN-OIL TYPE. | |
| JP2002501010A (en) | Cosmetic or pharmaceutical preparation with reduced stickiness, comprising a glycerol ester of an α-hydroxycarboxylic acid and a saturated fatty acid | |
| ES2230527T3 (en) | COMPOSITION CONTAINING CAFFEINE AS AN AGENT FOR SKIN CARE. | |
| ES2216234T3 (en) | USE OF BEE WAX TO REINFORCE THE UV-A PROTECTIVE FACTOR OF PHOTOPROTECTORS COSMETIC AND DERMATOLOGICAL PREPARATIONS. | |
| ES2216210T3 (en) | USE OF SYNTHETIC BEES WAX TO INCREASE THE PROTECTION FACTOR IN THE LIGHT OF COSMETIC OR DERMATOLOGICAL PHOTOPROTECTORS PRODUCTS. |